Shiyao Holding Group Co., Ltd. is a national-level innovative enterprise integrating research and development, production and sales of innovative drugs. The group has assets of more than 50 billion yuan and 27,000 employees. Companies listed in Hong Kong (01093.HK) have joined the club of 100 billion market capitalization and are members of the Hang Seng Index. It is also the first pharmaceutical stock in the 50-year history of the index. In 2019, its subsidiary company Xinnoway (300765.SZ) was successfully listed on the Growth Enterprise Market, and Shiyao Group realized A new era of "Red Chip +A" financing pattern.

At present in Hebei, Shanxi, Shandong, Jiangsu, Jiangxi, Tianjin and other provinces and cities with more than 10 drug production bases, product sales throughout the world more than 100 countries and regions, there are 35 varieties of single varieties sales more than 100 million yuan.